🇺🇸 FDA
Pipeline program

Xiang Sha Liu Jun Zi Decoction dry powder

CMUH109-REC1-085

Approved small_molecule completed

Quick answer

Xiang Sha Liu Jun Zi Decoction dry powder for Hepatocellular Carcinoma is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials